文献速递结核与非结核分枝杆菌艾滋病与性传播感染

治疗前2个月体重不增与HIV独立预测结核不良治疗结局

Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis.
PubMed 文献 · J Infect Dis · 2020-01-01

该前瞻性队列研究纳入巴西547例培养确诊的药物敏感肺结核成人患者,随访标准四药方案治疗。HIV感染者治疗2个月体重增幅较HIV阴性者少1.3 kg,且不良结局风险升高4.8倍;体重每增加1 kg,不良结局风险降低12%。

要点

  • HIV感染者结核治疗2个月体重增幅较HIV阴性者少1.3 kg
  • HIV感染使结核不良治疗结局风险升高4.8倍
  • 体重每增加1 kg,不良结局风险降低12%

核心结论

  • HIV感染者在结核治疗前2个月体重增幅较低,且体重不增与HIV感染独立预测结核不良治疗结局。

研究设计与样本

  • 前瞻性队列研究,纳入巴西547例培养确诊的药物敏感肺结核成人患者,接受标准四药方案治疗。

主要发现

  • 547例中102例(19%)HIV阳性,35例(6%)出现不良结局。
  • HIV感染者不良结局风险升高(调整风险比4.8,95%CI 2.1-10.9)。

临床怎么用

  • 体重是易于采集的生物标志物,可用于识别可能受益于替代治疗策略的结核患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Weight change may inform tuberculosis treatment response, but its predictive power may be confounded by human immunodeficiency virus (HIV). METHODS: We prospectively followed up adults with culture-confirmed, drug-susceptible, pulmonary tuberculosis receiving standard 4-drug therapy (isoniazid, rifampin, pyrazinamide, and ethambutol) in Brazil. We examined median weight change 2 months after treatment initiation by HIV status, using quantile regression, and unsuccessful tuberculosis treatment outcome (treatment failure, tuberculosis recurrence, or death) by HIV and weight change status, using Cox regression. RESULTS: Among 547 participants, 102 (19%) were HIV positive, and 35 (6%) had an unsuccessful outcome. After adjustment for confounders, persons living with HIV (PLWH) gained a median of 1.3 kg (95% confidence interval [CI], -2.8 to .1) less than HIV-negative individuals during the first 2 months of tuberculosis treatment. PLWH were at increased risk of an unsuccessful outcome (adjusted hazard ratio, 4.8; 95% CI, 2.1-10.9). Weight change was independently associated with outcome, with risk of unsuccessful outcome decreasing by 12% (95% CI, .81%-.95%) per 1-kg increase. CONCLUSIONS: PLWH gained less weight during the first 2 months of tuberculosis treatment, and lack of weight gain and HIV independently predicted unsuccessful tuberculosis treatment outcomes. Weight, an easily collected biomarker, may identify patients who would benefit from alternative treatment strategies.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Peetluk LS, Rebeiro PF, Cordeiro-Santos M, et al. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. J Infect Dis. 2020. PMID: 31724035. doi:10.1093/infdis/jiz595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。